Enliven Therapeutics, Inc. — All Filings
732 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-020605 | Jul 30, 2025 | Jul 28, 2025 |
| 144 | — | 0001974158-25-000048 | Jul 28, 2025 | — |
| 4 | — | 0001415889-25-020206 | Jul 23, 2025 | Jul 21, 2025 |
| 4 | — | 0001415889-25-020087 | Jul 21, 2025 | Jul 17, 2025 |
| 144 | — | 0001974158-25-000047 | Jul 21, 2025 | — |
| 144 | — | 0001974158-25-000046 | Jul 17, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-003029 | Jul 17, 2025 | — |
| 4 | — | 0001415889-25-019730 | Jul 14, 2025 | Jul 10, 2025 |
| 4 | — | 0001415889-25-019609 | Jul 9, 2025 | Jul 7, 2025 |
| 144 | — | 0001974158-25-000044 | Jul 7, 2025 | — |
| 4 | — | 0001415889-25-018718 | Jul 1, 2025 | Jun 27, 2025 |
| 144 | — | 0001974158-25-000043 | Jun 27, 2025 | — |
| 8-K | 8-K | 0001193125-25-146874 | Jun 25, 2025 | Jun 24, 2025 |
| 4 | — | 0001415889-25-018116 | Jun 24, 2025 | Jun 20, 2025 |
| 144 | — | 0001974158-25-000042 | Jun 20, 2025 | — |
| 4 | — | 0001415889-25-017730 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | — | 0001415889-25-017532 | Jun 17, 2025 | Jun 13, 2025 |
| SCHEDULE 13D/A | — | 0000947871-25-000616 | Jun 17, 2025 | — |
| 144 | — | 0001974158-25-000041 | Jun 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-141085 | Jun 16, 2025 | Jun 13, 2025 |
| 424B5 | 424B5 | 0001193125-25-140928 | Jun 16, 2025 | — |
| 8-K | 8-K | 0001193125-25-140285 | Jun 13, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-140298 | Jun 13, 2025 | — |
| S-3MEF | S-3MEF | 0001193125-25-140305 | Jun 13, 2025 | — |
| 144 | — | 0001974158-25-000040 | Jun 13, 2025 | — |
| 4 | — | 0001415889-25-016734 | Jun 11, 2025 | Jun 9, 2025 |
| 144 | — | 0001974158-25-000039 | Jun 9, 2025 | — |
| 4 | — | 0001415889-25-015787 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | — | 0001415889-25-015785 | Jun 5, 2025 | Jun 3, 2025 |
| 144 | — | 0001974158-25-000037 | Jun 3, 2025 | — |
| 144 | — | 0001974158-25-000038 | Jun 3, 2025 | — |
| 4 | — | 0001415889-25-014913 | May 29, 2025 | May 27, 2025 |
| 144 | — | 0001974158-25-000036 | May 27, 2025 | — |
| 4 | — | 0001415889-25-013992 | May 21, 2025 | May 19, 2025 |
| 4 | — | 0001415889-25-013993 | May 21, 2025 | May 19, 2025 |
| 144 | — | 0001974158-25-000035 | May 19, 2025 | — |
| 144 | — | 0001974158-25-000034 | May 19, 2025 | — |
| 8-K | 8-K | 0000950170-25-071387 | May 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-071412 | May 14, 2025 | Mar 31, 2025 |
| 4 | — | 0001415889-25-012591 | May 9, 2025 | May 7, 2025 |
| 144 | — | 0001974158-25-000031 | May 7, 2025 | — |
| 4 | — | 0001415889-25-012030 | May 5, 2025 | May 1, 2025 |
| 4 | — | 0001415889-25-012031 | May 5, 2025 | May 1, 2025 |
| 144 | — | 0001974158-25-000030 | May 1, 2025 | — |
| 144 | — | 0001974158-25-000029 | May 1, 2025 | — |
| 4 | — | 0001415889-25-011596 | Apr 30, 2025 | Apr 28, 2025 |
| DEF 14A | DEF 14A | 0001193125-25-100456 | Apr 28, 2025 | Jun 24, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-100481 | Apr 28, 2025 | — |
| ARS | ARS | 0001193125-25-100518 | Apr 28, 2025 | Dec 31, 2024 |
| 144 | — | 0001974158-25-000028 | Apr 28, 2025 | — |